<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04062396</url>
  </required_header>
  <id_info>
    <org_study_id>MCH2019-01</org_study_id>
    <nct_id>NCT04062396</nct_id>
  </id_info>
  <brief_title>Comparison of Remowell 2 and Inspire on Delirium and Cognitive Dysfunction</brief_title>
  <acronym>CRIDD</acronym>
  <official_title>Randomized Comparison Between Oxygenator Systems for the Reduction of Post-operative Delirium in Older Patients Undergoing Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maria Cecilia Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maria Cecilia Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Age is no longer an absolute contraindication to cardiac surgery therefore there is often
      need for combined interventions (double valve repair/replacement, or coronary artery bypass
      graft and valve repair/replacement) with relative prolongation of cardiopulmonary bypass
      time. Prolonged cardiopulmonary bypass use causes an increase in the inflammatory response,
      and on the other a need for blood reinfusion and therefore lipid microemboli from the
      operative field. The clinical consequences for patients are post-operative delirium and
      post-operative cognitive impairment.

      These two neurological complications involve up to 45% of elderly patients undergoing cardiac
      surgery and have a significant impact on quality of life, hospitalization and mortality in
      the short and long term. The Remowell 2 oxygenator system has demonstrated in preliminary
      studies that, compared to the gold standard Inspire oxygenator, it can guarantee a
      significant reduction of hemodilution, inflammatory systemic response and embolization of
      lipid microemboli and leukocytes. In light of these considerations, it is possible to
      formulate the hypothesis that the use of the Remowell 2 device can contribute to
      significantly reducing the onset of post-operative delirium and cognitive impairment. The
      present study is designed to validate this hypothesis in a randomized controlled scenario.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 26, 2019</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>post-operative delirium</measure>
    <time_frame>6 days</time_frame>
    <description>In-hospital incidence of post-operative delirium assessed by Confusion Assessment Method (CAM) diagnostic algorithm</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">314</enrollment>
  <condition>Cardiac Surgery</condition>
  <condition>Cardiopulmonary Bypass</condition>
  <arm_group>
    <arm_group_label>Eurosets REMOWELL 2 oxygenator</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>LivaNova INSPIRE oxygenator</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Eurosets REMOWELL 2 oxygenator</intervention_name>
    <description>The main characteristic of REMOWELL 2 oxygenator is the presence of a filtration system for extracavitary inlet. Multilayer cascade filtration and supernatant separator leads to lipid-leukocytes depletion</description>
    <arm_group_label>Eurosets REMOWELL 2 oxygenator</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LivaNova INSPIRE oxygenator</intervention_name>
    <description>INSPIRE oxygenator has no filtration system for extracavitary inlet</description>
    <arm_group_label>LivaNova INSPIRE oxygenator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Signature of informed consent for participation in the study

          2. Age â‰¥65 years

          3. Patients undergoing cardiac surgery of:

               1. coronary artery bypass graft and concomitant valve replacement/repair OR

               2. double valve replacement/repair

        Exclusion Criteria:

          1. Any documented history of cognitive impairment estimated as a mini mental state
             examination &lt; 24 points

          2. Patients who need blood prime in the cardiopulmonary bypass circuit

          3. Chronic coagulopathies ( international normalized ratio &gt; 2 in patients without
             anticoagulant treatment)

          4. End stage renal disease on dialysis treatment

          5. Previous cerebrovascular accident

          6. Active cancer or immunological diseases

          7. Liver cirrhosis (platelets &lt;100.000/uL)

          8. Decompensated diabetes

          9. Severe preoperative anemia (hemoglobin &lt;8 g/dl).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lorenzo Mantovani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maria Cecilia Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paolo Cimaglia, MD</last_name>
    <phone>0545217031</phone>
    <phone_ext>+39</phone_ext>
    <email>pcimaglia@gvmnet.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Maria Cecilia Hospital</name>
      <address>
        <city>Cotignola</city>
        <state>Ravenna</state>
        <zip>48010</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paolo Cimaglia, MD</last_name>
      <phone>0545217031</phone>
      <phone_ext>+39</phone_ext>
      <email>pcimaglia@gvmnet.it</email>
    </contact>
    <investigator>
      <last_name>Lorenzo Mantovani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 19, 2019</study_first_submitted>
  <study_first_submitted_qc>August 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2019</study_first_posted>
  <last_update_submitted>September 27, 2019</last_update_submitted>
  <last_update_submitted_qc>September 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

